Hatsuyo Kano

1.0k total citations
18 papers, 824 citations indexed

About

Hatsuyo Kano is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Hatsuyo Kano has authored 18 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Physiology. Recurrent topics in Hatsuyo Kano's work include Hormonal Regulation and Hypertension (7 papers), Nitric Oxide and Endothelin Effects (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Hatsuyo Kano is often cited by papers focused on Hormonal Regulation and Hypertension (7 papers), Nitric Oxide and Endothelin Effects (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Hatsuyo Kano collaborates with scholars based in Japan and United States. Hatsuyo Kano's co-authors include Toshio Hayashi, Akihisa Iguchi, Daigo Sumi, Navin Kumar Thakur, Taku Tsunekawa, Hisako Matsui‐Hirai, Yukako Asai, Muthuvel Jayachandran, Teiji Esaki and Kensuke Egashira and has published in prestigious journals such as Circulation, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

Hatsuyo Kano

17 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hatsuyo Kano Japan 15 263 247 217 208 156 18 824
Hisako Matsui‐Hirai Japan 15 204 0.8× 237 1.0× 155 0.7× 368 1.8× 260 1.7× 18 1.0k
Navin Kumar Thakur Japan 10 235 0.9× 175 0.7× 159 0.7× 149 0.7× 113 0.7× 11 597
Concetta Di Febbo Italy 18 184 0.7× 255 1.0× 82 0.4× 176 0.8× 215 1.4× 31 1.0k
Kirsten Müller Germany 6 528 2.0× 348 1.4× 218 1.0× 225 1.1× 277 1.8× 11 1.2k
Markus Lassila Finland 21 182 0.7× 331 1.3× 412 1.9× 189 0.9× 490 3.1× 34 1.5k
Rémy Chenevard Switzerland 10 184 0.7× 444 1.8× 95 0.4× 185 0.9× 186 1.2× 13 1.1k
Javier Navarro-Antolı́n Spain 12 402 1.5× 303 1.2× 133 0.6× 296 1.4× 295 1.9× 14 1.1k
Klaus Kusterer Germany 20 403 1.5× 82 0.3× 236 1.1× 231 1.1× 221 1.4× 51 1.1k
Agnès Sassolas France 21 388 1.5× 412 1.7× 412 1.9× 212 1.0× 312 2.0× 43 1.2k
Toshitaka TAMAI Japan 13 392 1.5× 268 1.1× 259 1.2× 120 0.6× 230 1.5× 44 890

Countries citing papers authored by Hatsuyo Kano

Since Specialization
Citations

This map shows the geographic impact of Hatsuyo Kano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatsuyo Kano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatsuyo Kano more than expected).

Fields of papers citing papers by Hatsuyo Kano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatsuyo Kano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatsuyo Kano. The network helps show where Hatsuyo Kano may publish in the future.

Co-authorship network of co-authors of Hatsuyo Kano

This figure shows the co-authorship network connecting the top 25 collaborators of Hatsuyo Kano. A scholar is included among the top collaborators of Hatsuyo Kano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatsuyo Kano. Hatsuyo Kano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hayashi, Toshio, Daigo Sumi, Hisako Matsui‐Hirai, et al.. (2003). Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism. Atherosclerosis. 168(1). 23–31. 54 indexed citations
2.
Tsunekawa, Taku, Toshio Hayashi, Yusuke Suzuki, et al.. (2003). Plasma Adiponectin Plays an Important Role in Improving Insulin Resistance With Glimepiride in Elderly Type 2 Diabetic Subjects. Diabetes Care. 26(2). 285–289. 83 indexed citations
3.
Thakur, Navin Kumar, Toshio Hayashi, Daigo Sumi, et al.. (2002). Anti-Atherosclerotic Effect of β-Blocker with Nitric Oxide–Releasing Action on the Severe Atherosclerosis. Journal of Cardiovascular Pharmacology. 39(2). 298–309. 16 indexed citations
4.
Nomura, Hideki, Toshio Hayashi, Teiji Esaki, et al.. (2002). Standardization of Plasma Brain Natriuretic Peptide Concentrations in Older Japanese—Relationship to Latent Renal Dysfunction and Ischemic Heart Disease. Journal of the American Geriatrics Society. 50(9). 1504–1509. 17 indexed citations
5.
Kano, Hatsuyo, Toshio Hayashi, Daigo Sumi, et al.. (2002). Estriol retards and stabilizes atherosclerosis through an NO-mediated system. Life Sciences. 71(1). 31–42. 15 indexed citations
6.
Jayachandran, Muthuvel, Toshio Hayashi, Daigo Sumi, et al.. (2001). Up-Regulation of Endothelial Nitric Oxide Synthase through β2-Adrenergic Receptor—The Role of a β-Blocker with NO-Releasing Action. Biochemical and Biophysical Research Communications. 280(3). 589–594. 25 indexed citations
7.
Thakur, Navin Kumar, Toshio Hayashi, Daigo Sumi, et al.. (2001). HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide. American Journal of Physiology-Heart and Circulatory Physiology. 281(1). H75–H83. 37 indexed citations
8.
9.
Tsunekawa, Taku, Toshio Hayashi, Hatsuyo Kano, et al.. (2001). Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days. Circulation. 104(4). 376–379. 202 indexed citations
10.
Hayashi, Toshio, Muthuvel Jayachandran, Daigo Sumi, et al.. (2000). Physiological Concentration of 17β-Estradiol Retards the Progression of Severe Atherosclerosis Induced by a High-Cholesterol Diet Plus Balloon Catheter Injury. Arteriosclerosis Thrombosis and Vascular Biology. 20(6). 1613–1621. 36 indexed citations
11.
Hayashi, Toshio, et al.. (2000). Estriol (E3) Replacement Improves Endothelial Function and Bone Mineral Density in Very Elderly Women. The Journals of Gerontology Series A. 55(4). B183–B190. 26 indexed citations
12.
13.
Hayashi, Toshio, Teiji Esaki, Emiko Muto, et al.. (2000). Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen. Arteriosclerosis Thrombosis and Vascular Biology. 20(3). 782–792. 87 indexed citations
14.
Kano, Hatsuyo, Toshio Hayashi, Daigo Sumi, et al.. (1999). A HMG-CoA Reductase Inhibitor Improved Regression of Atherosclerosis in the Rabbit Aorta without Affecting Serum Lipid Levels: Possible Relevance of Up-Regulation of Endothelial NO Synthase mRNA. Biochemical and Biophysical Research Communications. 259(2). 414–419. 60 indexed citations
15.
Hayashi, Toshio, Kazuyoshi Yamada, Teiji Esaki, et al.. (1999). Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO−). Atherosclerosis. 147(2). 349–363. 27 indexed citations
16.
Esaki, Teiji, et al.. (1997). Expression of inducible nitric oxide synthase in T lymphocytes and macrophages in vessels with advanced atherosclerosis.. PubMed. Suppl 12. 89–92. 8 indexed citations
17.
Hayashi, Toshio, Hatsuyo Kano, Yukako Asai, et al.. (1997). 2.P.304 17 β estradiol retard the progression of severe atherosclerosis induced by high cholesterol diet plus baloon injury: The relation of NO. Atherosclerosis. 134(1-2). 180–180. 1 indexed citations
18.
Kohno, Masakazu, Koji Yokokawa, K. Yasunari, et al.. (1997). Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.. PubMed. 35(1). 38–42. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisako Matsui‐Hirai Breakdown of academic impact, for papers by Navin Kumar Thakur Breakdown of academic impact, for papers by Concetta Di Febbo Breakdown of academic impact, for papers by Kirsten Müller Breakdown of academic impact, for papers by Markus Lassila Breakdown of academic impact, for papers by Rémy Chenevard Breakdown of academic impact, for papers by Javier Navarro-Antolı́n Breakdown of academic impact, for papers by Klaus Kusterer Breakdown of academic impact, for papers by Agnès Sassolas Breakdown of academic impact, for papers by Toshitaka TAMAI
Rankless by CCL
2026